Nelson, Van Denburg & Campbell Wealth Management »

Nautilus Biotechnology shares owned by Nelson, Van Denburg & Campbell Wealth Management

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Nelson, Van Denburg & Campbell Wealth Management from 13F filings

Historical chart of Nelson, Van Denburg & Campbell Wealth Management investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Nelson, Van Denburg & Campbell Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Nelson, Van Denburg & Campbell Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $23k 14k 1.68
2024-09-30 $36k 13k 2.85
2024-06-30 $30k 13k 2.34
2024-03-31 $62k 21k 2.94

More positions owned by Nelson, Van Denburg & Campbell Wealth Management

Vanguard Growth Etf Etf (VUG)
Ishares Core Dividend Growth Etf Etf (DGRO)
Vanguard Mid Cap Growth Etf Etf (VOT)
Vanguard Index Fds Mid-cap Value Index Viper Shs Etf Etf (VOE)
Ishares S&p 500 Index Etf (IVV)
Jpmorgan Active Value Etf Etf (JAVA)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Jpmorgan Active Growth Etf Etf (JGRO)
Apple Stock (AAPL)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)
Invesco Bulletshares 2029 Corporate Bond Etf Etf (BSCT)
Invesco Bulletshares 2027 Corporate Bond Etf Etf (BSCR)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Small Cap Growth Etf Etf (VBK)

View all positions for Nelson, Van Denburg & Campbell Wealth Management

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
BlackRock
Vanguard Group
Comprehensive Financial Management
Bain Capital Life Sciences Investors
Amazon
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Tikvah Management
Clarius
Botty Investors

View all funds holding Nautilus Biotechnology